Geoffrey D. Miller

1.2k total citations · 1 hit paper
39 papers, 980 citations indexed

About

Geoffrey D. Miller is a scholar working on Endocrinology, Diabetes and Metabolism, Cell Biology and Hematology. According to data from OpenAlex, Geoffrey D. Miller has authored 39 papers receiving a total of 980 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Cell Biology and 13 papers in Hematology. Recurrent topics in Geoffrey D. Miller's work include Hormonal and reproductive studies (18 papers), Muscle metabolism and nutrition (15 papers) and Erythropoietin and Anemia Treatment (9 papers). Geoffrey D. Miller is often cited by papers focused on Hormonal and reproductive studies (18 papers), Muscle metabolism and nutrition (15 papers) and Erythropoietin and Anemia Treatment (9 papers). Geoffrey D. Miller collaborates with scholars based in United States, Germany and Belgium. Geoffrey D. Miller's co-authors include Carol S. Lim, Benjamin Bruno, Daniel Eichner, Holly D. Cox, Daniel M. Cushman, Stuart E. Willick, Peter Van Eenoo, Masaru Teramoto, Matthew Fedoruk and David W. Woessner and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The Journal of Physiology and Scientific Reports.

In The Last Decade

Geoffrey D. Miller

35 papers receiving 930 citations

Hit Papers

Basics and Recent Advance... 2013 2026 2017 2021 2013 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Basics and Recent Advances in Peptide and Protein Drug Delivery
    2013 577 citations Benjamin Bruno, Geoffrey D. Miller et al. Therapeutic Delivery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoffrey D. Miller United States 13 426 183 157 154 129 39 980
Benjamin Bruno United States 12 560 1.3× 61 0.3× 105 0.7× 156 1.0× 62 0.5× 24 1.1k
Susan C. Low United States 15 754 1.8× 68 0.4× 266 1.7× 79 0.5× 30 0.2× 29 1.6k
Mark Knapp United States 17 769 1.8× 63 0.3× 38 0.2× 35 0.2× 68 0.5× 24 1.2k
Gunvor Alvélius Sweden 21 631 1.5× 143 0.8× 57 0.4× 11 0.1× 55 0.4× 42 1.4k
Jurgen Joossens Belgium 23 678 1.6× 136 0.7× 36 0.2× 56 0.4× 17 0.1× 58 1.9k
Susumu Hama Japan 25 1.0k 2.4× 50 0.3× 27 0.2× 209 1.4× 61 0.5× 55 1.8k
Yingqiu Xie Kazakhstan 27 1.1k 2.7× 105 0.6× 95 0.6× 8 0.1× 119 0.9× 80 2.0k
Sohee Son South Korea 18 743 1.7× 154 0.8× 17 0.1× 189 1.2× 32 0.2× 44 1.4k
William R. Wolter United States 21 502 1.2× 172 0.9× 41 0.3× 18 0.1× 17 0.1× 47 1.5k
Feifei Yang China 23 748 1.8× 19 0.1× 48 0.3× 89 0.6× 79 0.6× 83 1.5k

Countries citing papers authored by Geoffrey D. Miller

Since Specialization
Citations

This map shows the geographic impact of Geoffrey D. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey D. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey D. Miller more than expected).

Fields of papers citing papers by Geoffrey D. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey D. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey D. Miller. The network helps show where Geoffrey D. Miller may publish in the future.

Co-authorship network of co-authors of Geoffrey D. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey D. Miller. A scholar is included among the top collaborators of Geoffrey D. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey D. Miller. Geoffrey D. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faiss, Raphaël, Yvette Dehnes, Geoffrey D. Miller, et al.. (2025). Endocrine and androgenic response to altitude training in professional cyclists. The Journal of Physiology.
2.
Sakellariou, P., Katja Walpurgis, Andreas Thomas, et al.. (2025). Combined detection of inhibitors of the activin receptor signaling pathways (IASPs) by means of LC-HRMS/MS for human doping control. Scientific Reports. 15(1). 19887–19887.
3.
4.
Lewis, Laura A., et al.. (2024). Comparison of Microcapillary Blood Sampling Devices for Use in Anti‐Doping. Drug Testing and Analysis. 17(8). 1145–1149. 2 indexed citations
5.
Miller, Geoffrey D., et al.. (2024). Evaluation of Minimum Reporting Limits to Determine In‐Competition Use of Stimulants. Drug Testing and Analysis. 17(6). 915–922.
6.
7.
Mürdter, Thomas E., Georg Heinkele, Matthias Schwab, et al.. (2023). Identification and synthesis of ( Z )‐3′‐hydroxy clomiphene as a new potential doping‐relevant metabolite of clomiphene. Rapid Communications in Mass Spectrometry. 37(17). e9599–e9599. 5 indexed citations
8.
Eichner, Daniel, et al.. (2023). Impact of Biotin Supplementation on Human Chorionic Gonadotropin Immunoassays Utilizing Biotin-Streptavidin Binding Methods in Urine. Clinical Chemistry. 69(7). 754–762. 4 indexed citations
9.
Fedoruk, Matthew, et al.. (2022). Feasibility of microvolumetric capillary whole blood collections for usage in Athlete Biological Passport analysis. Drug Testing and Analysis. 14(7). 1291–1299. 15 indexed citations
10.
Loria, Francesco, Holly D. Cox, Sven Christian Voss, et al.. (2021). The use of RNA‐based 5'‐aminolevulinate synthase 2 biomarkers in dried blood spots to detect recombinant human erythropoietin microdoses. Drug Testing and Analysis. 14(5). 826–832. 17 indexed citations
11.
12.
Miller, Geoffrey D., et al.. (2020). Potential for dehydration to impact the athlete biological passport. Drug Testing and Analysis. 12(8). 1206–1211. 10 indexed citations
13.
Miller, Geoffrey D., et al.. (2019). Investigating oral fluid and exhaled breath as alternative matrices for anti-doping testing: Analysis of 521 matched samples. Journal of Pharmaceutical and Biomedical Analysis. 176. 112810–112810. 11 indexed citations
14.
Miller, Geoffrey D., et al.. (2019). Hematological changes following an Ironman triathlon: An antidoping perspective. Drug Testing and Analysis. 11(11-12). 1747–1754. 8 indexed citations
15.
Cox, Holly D., et al.. (2017). Detection of autologous blood transfusions using a novel dried blood spot method. Drug Testing and Analysis. 9(11-12). 1713–1720. 31 indexed citations
16.
Miller, Geoffrey D., et al.. (2016). Intranasal delivery of Natesto® testosterone gel and its effects on doping markers. Drug Testing and Analysis. 8(11-12). 1197–1203. 12 indexed citations
17.
Willick, Stuart E., Geoffrey D. Miller, & Daniel Eichner. (2016). The Anti‐Doping Movement. PM&R. 8(3S). S125–32. 13 indexed citations
18.
Lim, Carol S., Geoffrey D. Miller, & Benjamin Bruno. (2014). Resistant mutations in CML and Ph+ALL – role of ponatinib. Biologics. 8. 243–243. 69 indexed citations
19.
Bruno, Benjamin, Geoffrey D. Miller, & Carol S. Lim. (2013). Basics and Recent Advances in Peptide and Protein Drug Delivery. Therapeutic Delivery. 4(11). 1443–1467. 577 indexed citations breakdown →
20.
Miller, Geoffrey D., et al.. (2003). Mass spectrometry-compatible ICH (International Conference on Harmonization) impurity analysis with a high-pH mobile phase. Journal of Chromatography A. 987(1-2). 283–290. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Bruno Breakdown of academic impact, for papers by Susan C. Low Breakdown of academic impact, for papers by Mark Knapp Breakdown of academic impact, for papers by Gunvor Alvélius Breakdown of academic impact, for papers by Jurgen Joossens Breakdown of academic impact, for papers by Susumu Hama Breakdown of academic impact, for papers by Yingqiu Xie Breakdown of academic impact, for papers by Sohee Son Breakdown of academic impact, for papers by William R. Wolter Breakdown of academic impact, for papers by Feifei Yang
Rankless by CCL
2026